Treatment outcome in patients with HCV Genotype-3a Infection, Treated with 24-Weeks Dual Therapy (Sofosbuvir and Ribavirin). (2024). Medical Forum Monthly, 28(11). https://medicalforummonthly.com/index.php/mfm/article/view/4275